Zivo Bioscience, Inc.
ZIVO
$14.85
-$0.15-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.80K | 517.20K | 1.54M | 159.40K | 2.50K |
| Total Receivables | 34.40K | -- | 2.20K | 27.80K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 365.70K | 505.70K | 90.80K | 249.30K | 492.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 409.90K | 1.02M | 1.64M | 436.50K | 495.10K |
|
|
|||||
| Total Current Assets | 409.90K | 1.02M | 1.64M | 436.50K | 495.10K |
| Net Property, Plant & Equipment | 285.80K | 300.70K | -- | 22.30K | 48.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.70K | 7.70K | 7.70K | 36.70K | 32.10K |
| Total Assets | 703.30K | 1.33M | 1.64M | 495.60K | 575.60K |
|
|
|||||
| Total Accounts Payable | 931.00K | 655.30K | 741.90K | 923.90K | 1.17M |
| Total Accrued Expenses | 1.50M | 1.29M | 1.16M | 1.23M | 1.10M |
| Short-term Debt | -- | 439.40K | -- | 115.00K | 287.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 494.60K | 199.30K | 138.20K | 262.00K | 290.90K |
| Total Finance Division Other Current Liabilities | 34.40K | 28.80K | -- | 45.00K | 15.00K |
| Total Other Current Liabilities | 34.40K | 28.80K | -- | 45.00K | 15.00K |
| Total Current Liabilities | 2.96M | 2.61M | 2.04M | 2.58M | 2.87M |
|
|
|||||
| Total Current Liabilities | 2.96M | 2.61M | 2.04M | 2.58M | 2.87M |
| Long-Term Debt | 47.00K | 81.50K | 116.20K | -- | -- |
| Short-term Debt | -- | 439.40K | -- | 115.00K | 287.50K |
| Capital Leases | 237.50K | 254.50K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.24M | 2.95M | 2.16M | 2.58M | 2.87M |
|
|
|||||
| Common Stock & APIC | 140.28M | 139.56M | 136.45M | 133.28M | 130.80M |
| Retained Earnings | -142.82M | -141.18M | -136.97M | -135.37M | -133.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.54M | -1.62M | -514.90K | -2.08M | -2.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.54M | -1.62M | -514.90K | -2.08M | -2.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.54M | -1.62M | -514.90K | -2.08M | -2.30M |
|
|
|||||